Literature DB >> 27663666

Advancing the use of noncoding RNA in regulatory toxicology: Report of an ECETOC workshop.

Achim Aigner1, Roland Buesen2, Tim Gant3, Nigel Gooderham4, Helmut Greim5, Jörg Hackermüller6, Bruno Hubesch7, Madeleine Laffont8, Emma Marczylo3, Gunter Meister9, Jay S Petrick10, Reza J Rasoulpour11, Ursula G Sauer12, Kerstin Schmidt13, Hervé Seitz14, Frank Slack15, Tokuo Sukata16, Saskia M van der Vies17, Jan Verhaert18, Kenneth W Witwer19, Alan Poole20.   

Abstract

The European Centre for the Ecotoxicology and Toxicology of Chemicals (ECETOC) organised a workshop to discuss the state-of-the-art research on noncoding RNAs (ncRNAs) as biomarkers in regulatory toxicology and as analytical and therapeutic agents. There was agreement that ncRNA expression profiling data requires careful evaluation to determine the utility of specific ncRNAs as biomarkers. To advance the use of ncRNA in regulatory toxicology, the following research priorities were identified: (1) Conduct comprehensive literature reviews to identify possibly suitable ncRNAs and areas of toxicology where ncRNA expression profiling could address prevailing scientific deficiencies. (2) Develop consensus on how to conduct ncRNA expression profiling in a toxicological context. (3) Conduct experimental projects, including, e.g., rat (90-day) oral toxicity studies, to evaluate the toxicological relevance of the expression profiles of selected ncRNAs. Thereby, physiological ncRNA expression profiles should be established, including the biological variability of healthy individuals. To substantiate the relevance of key ncRNAs for cell homeostasis or pathogenesis, molecular events should be dose-dependently linked with substance-induced apical effects. Applying a holistic approach, knowledge on ncRNAs, 'omics and epigenetics technologies should be integrated into adverse outcome pathways to improve the understanding of the functional roles of ncRNAs within a regulatory context. Crown Copyright Â
© 2016. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adverse-outcome-pathway; Biomarker; Gene expression; Noncoding RNA (ncRNA); Phenotypic consequence; Regulatory toxicology

Mesh:

Substances:

Year:  2016        PMID: 27663666     DOI: 10.1016/j.yrtph.2016.09.018

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  3 in total

1.  Toxicoepigenetics for Risk Assessment: Bridging the Gap Between Basic and Regulatory Science.

Authors:  Anne Le Goff; Séverine Louvel; Henri Boullier; Patrick Allard
Journal:  Epigenet Insights       Date:  2022-07-15

2.  Embracing the Dark Side: Computational Approaches to Unveil the Functionality of Genes Lacking Biological Annotation in Drug-Induced Liver Injury.

Authors:  Terezinha Souza; Panuwat Trairatphisan; Janet Piñero; Laura I Furlong; Julio Saez-Rodriguez; Jos Kleinjans; Danyel Jennen
Journal:  Front Genet       Date:  2018-11-20       Impact factor: 4.599

3.  Transcriptional Responses Reveal Similarities Between Preclinical Rat Liver Testing Systems.

Authors:  Zhichao Liu; Brian Delavan; Ruth Roberts; Weida Tong
Journal:  Front Genet       Date:  2018-03-20       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.